ETAP-Lab - Preclinical Efficacy CRO

At a glimpse ETAP-Lab is a French preclinical CRO with over 30 years' expertise in derisking research & advancing drug development for pharmaceutical and biotech companies. Our expertise covers dermatological, cardiological, neurovascular and neurological diseases thanks to our dedicated research labs. Our range of services • A portfolio of over 60 tried-and-tested in vitro and in vivo reference models. • Proof of concept & pharmacological experiments • Efficacy & safety studies Working with us • Personalized & expert advisory • Tailor-made & flexible study designs Constant innovation & validated methods • Technical expertise & production facilities • Advanced technological capabilities • Robustness, Translational-approach, & Expertise • ISO9001 quality approach Our unique approach By respecting rodent chronobiology and natural behaviors, ETAP-Lab proposes research models with added translational value. Our experts aim to provide our clients with the most relevant data using state-of-the-art techniques and imaging, still to offer better predictability of compounds' efficacy. Tailored services Beyond expertise, our flexible and human-sized organization can design and operate tailored drug efficacy studies to fit client's needs. Focus on our 4 dedicated labs of excellence • Dermatology lab: portfolio of original in vivo rodent models such as psoriasis, atopic dermatitis, wound healing, ischemic ulceration & skin grafting… • Cardiology lab: SYNCROSOME's range of services in cardiovascular & respiratory diseases models such as HFrEF, HFpEF & PAH. LinkedIn Page: https://www.linkedin.com/company/syncrosome • Neurovascular/Stroke lab: STROK@LLIANCE, leader in the field of preclinical stroke research, offering Ischemic Stroke, Hemorrhagic Stroke & Thrombo-embolic stroke models. • Neurology lab: from in vitro to in vivo solutions, for Proteinopathies with our own oligomers (AD's, PD's) & psychopharmacology. Check out our portfolio of models!